Alzheimer's Disease Trial, Recruiting NCT05748613 Sponsor: Florida State University Condition: Alzheimer's Disease
Back to Alzheimers Disease

Alzheimer's Disease Trial, Recruiting

NCT05748613
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The trial involves a patient aged 60 or older and a care partner aged 18 or older joining together as a pair.
  • The care partner is someone who has a reciprocal relationship with the patient, providing emotional or physical support and help with decision-making — such as a spouse, partner, relative, or close friend who spends significant time with the patient.
  • The patient and care partner together have access to a smartphone or Wi-Fi.
  • The patient scores 20 or above on a standard anxiety questionnaire (PROMIS-Anxiety short form), OR scores 5 or above on a sleep and anxiety scale (SSASI), OR scores 31 or above on a perceived stress scale (NIH Toolbox Perceived Stress Scale).
  • In addition to the above, at least one of the following applies: the patient scores between 17 and 26 on a memory and thinking assessment (MoCA), OR the patient scores 3 or greater on a memory complaint scale, OR the care partner scores between 2 and 12.5 on a dementia rating scale completed about the patient.

Who may not be able to join:

  • Patients who have vision or hearing difficulties that would prevent them from reading or listening to computer-based presentations.
  • Patients who have medical conditions that would prevent them from taking part in the study (confirm with trial site).
  • Patients who have a severe mental health condition, such as schizophrenia or bipolar disorder that is not being treated with medication.
  • Care partners who have vision or hearing difficulties that would prevent them from reading or listening to computer-based presentations.
  • Care partners who have medical conditions that would prevent them from taking part in the study (confirm with trial site).
  • Care partners who have a severe mental health condition, such as schizophrenia or bipolar disorder that is not being treated with medication.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8506451766

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Florida State University
Registry
ClinicalTrials.gov
Start date
2 November 2023
Est. completion
1 June 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in anxiety sensitivity pre intervention to posttreatment.; Change in anxiety pre intervention to 1-month follow-up.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov